title: Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors.
abstract: Transforming growth factor (TGF)-beta1-decreased major histocompatibility complex (MHC) class I gene expression in thyrocytes is transcriptional; it involves trans factors and cis elements important for hormone- as well as iodide-regulated thyroid growth and function. Thus, in rat FRTL-5 thyrocytes, TGF-beta1 regulates two elements within -203 bp of the transcription start site of the MHC class I 5'-flanking region: Enhancer A, -180 to -170 bp, and a downstream regulatory element (DRE), -127 to -90 bp, that contains a cAMP response element (CRE)-like sequence. TGF-beta1 reduces the interaction of a NF-kappaB p50/fra-2 heterodimer (MOD-1) with Enhancer A while increasing its interaction with a NF-kappaB p50/p65 heterodimer. Both reduced MOD-1 and increased p50/p65 suppresses class I expression. Decreased MOD-1 and increased p50/p65 have been separately associated with the ability of autoregulatory (high) concentrations of iodide to suppress thyrocyte growth and function, as well as MHC class I expression. TGF-beta1 has two effects on the downstream regulatory element (DRE). It increases DRE binding of a ubiquitously expressed Y-box protein, termed TSEP-1 (TSHR suppressor element binding protein-1) in rat thyroid cells; TSEP-1 has been shown separately to be an important suppressor of the TSH receptor (TSHR) in addition to MHC class I and class II expression. It also decreases the binding of a thyroid-specific trans factor, thyroid transcription factor-1 (TTF-1), to the DRE, reflecting the ability of TGF-beta1 to decrease TTF-1 RNA levels. TGF-beta1-decreased TTF-1 expression accounts in part for TGF-beta1-decreased thyroid growth and function, since decreased TTF-1 has been shown to decrease thyroglobulin, thyroperoxidase, sodium iodide symporter, and TSHR gene expression, coincident with decreased MHC class I. Finally, we show that TGF-beta1 increases c-jun RNA levels and induces the formation of new complexes involving c-jun, fra-2, ATF-1, and c-fos, which react with Enhancer A and the DRE. TGF-beta1 effects on c-jun may be a pivotal fulcrum in the hitherto unrecognized coordinate regulation of Enhancer A and the DRE.
authors.affiliation: Department of Medicine, University G. D'Annunzio, Chieti, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Napolitano
authors.forename: V
authors.initials: V
authors.lastname: Montani
authors.forename: C
authors.initials: C
authors.lastname: Giuliani
authors.forename: S
authors.initials: S
authors.lastname: Di Vincenzo
authors.forename: I
authors.initials: I
authors.lastname: Bucci
authors.forename: V
authors.initials: V
authors.lastname: Todisco
authors.forename: G
authors.initials: G
authors.lastname: Laglia
authors.forename: A
authors.initials: A
authors.lastname: Coppa
authors.forename: D S
authors.initials: DS
authors.lastname: Singer
authors.forename: M
authors.initials: M
authors.lastname: Nakazato
authors.forename: L D
authors.initials: LD
authors.lastname: Kohn
authors.forename: G
authors.initials: G
authors.lastname: Colletta
authors.forename: F
authors.initials: F
authors.lastname: Monaco
mesh_terms: D000818:Animals; D023181:Antimicrobial Cationic Peptides; D022762:CCAAT-Enhancer-Binding Proteins; D002460:Cell Line; D000242:Cyclic AMP / Q000494:pharmacology; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D019281:Dimerization; D004742:Enhancer Elements, Genetic; D005786:Gene Expression Regulation / Q000187:drug effects*; D005805:Genes, MHC Class I; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism / Q000494:pharmacology; D051839:NFI Transcription Factors; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism; D051381:Rats; D012045:Regulatory Sequences, Nucleic Acid; D020218:Response Elements; D013961:Thyroid Gland / Q000276:immunology*; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D051840:Y-Box-Binding Protein 1
chemical_list: D023181:Antimicrobial Cationic Peptides; D022762:CCAAT-Enhancer-Binding Proteins; D017362:Cyclic AMP Response Element-Binding Protein; D004268:DNA-Binding Proteins; D016328:NF-kappa B; D051839:NFI Transcription Factors; C000614412:NKX2-1 protein, human; C000614416:Nkx2-1 protein, rat; D009687:Nuclear Proteins; D010455:Peptides; D016755:Proto-Oncogene Proteins c-jun; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D051840:Y-Box-Binding Protein 1; C070856:YBX1 protein, human; C089689:modelin 1; D000242:Cyclic AMP